Citation Impact
Citing Papers
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
2020 Standout
Inhibitory effect of minocycline on amyloid β fibril formation and human microglial activation
2005
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
2008 Standout
Chemoprophylaxis is Effective in the Prevention of Leprosy in Endemic Countries: a Systematic Review and Meta-Analysis
2000
Soluble tumor necrosis factor-α receptor type 1 during selenium supplementation in psoriasis patients
2003
Mycosis Fungoides and Sezary Syndrome
2017
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
2010
IFN‐α/β enhances BCR‐dependent B cell responses
2002
Treatment of Adamantiades-Behçet Disease With Systemic Interferon Alfa
1998
INTERFERON-?? TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RECIPIENTS OF SOLID ORGAN TRANSPLANTS1
1998
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
2017
Pemphigus: Etiology, pathogenesis, and inducing or triggering factors: Facts and controversies
2013 Standout
Treatment of Cutaneous T Cell Lymphoma
2002
Leprosy
2004 Standout
IgG4-related disease
2014 Standout
Behçet's Disease
1999 Standout
Epstein–Barr Virus Infection
2000 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Romidepsin: A Histone Deacetylase Inhibitor for Refractory Cutaneous T-Cell Lymphoma
2012
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Detection of Phenolic Glycolipid I of Mycobacterium leprae in Sera from Leprosy Patients before and after Start of Multidrug Therapy
2001
Interferon in the Treatment of Cutaneous T-cell Lymphoma
1995
Plantar focal idiopathic hyperhidrosis and botulinum toxin: a pilot study.
2007
Natural product and natural product derived drugs in clinical trials
2014 Standout
Fibrohistiocytic Tumors and Related Neoplasms in Children and Adolescents
2012
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
2007 Standout
CutaneousT ‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
2015
A retrospective comparative outcome analysis following systemic therapy in M ycosis fungoides and S ezary syndrome
2016
How I treat mycosis fungoides and Sézary syndrome
2016
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.
2001
Works of P. Celérier being referenced
Prospective Multicenter Study of Pegylated Liposomal Doxorubicin Treatment in Patients With Advanced or Refractory Mycosis Fungoides or Sézary Syndrome
2008
Long-Term Interferon-Alpha Therapy Induces Autoantibodies against Epidermis
1996
Modulatory effects of selenium and strontium salts on keratinocyte-derived inflammatory cytokines
1995
Roferon-A in Combination with Tigason in Cutaneous T-Cell Lymphomas
1993
In vitro modulation of epidermal inflammatory cytokines (IL-1α, IL-6, TNFα) by minocycline
1996
Histiocytome congénital : une lésion bénigne
2009
Evidence for a complement-mediated inhibition and an antibody-dependent cellular cytotoxicity of dermal fibroblasts in alopecia areata.
1994
[Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
2003
PGL-I antigen and antibody detection in leprosy patients: evolution under chemotherapy.
1989
Implementation of chemoprophylaxis of leprosy in the Southern Marquesas with a single dose of 25 mg per kg rifampin.
1989